Avrobio Inc (AVRO)

1.39 0.00 (0.00%) USD  |  NASDAQ  |  May 17, 16:00
1.39 0.00 (0.00%) After-Hours: 20:00
More

Avrobio Cash from Operations (Quarterly): -7.569M for March 31, 2024

Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2017. Upgrade now.
Date Value
March 31, 2024 -7.569M
December 31, 2023 -8.031M
September 30, 2023 -20.22M
June 30, 2023 -14.65M
March 31, 2023 -20.28M
December 31, 2022 -23.67M
September 30, 2022 -16.42M
June 30, 2022 -29.11M
March 31, 2022 -28.01M
December 31, 2021 -25.90M
September 30, 2021 -24.82M
June 30, 2021 -19.96M
March 31, 2021 -27.34M
December 31, 2020 -30.49M
September 30, 2020 -24.86M
Date Value
June 30, 2020 -21.02M
March 31, 2020 -22.43M
December 31, 2019 -18.58M
September 30, 2019 -13.38M
June 30, 2019 -17.96M
March 31, 2019 -17.74M
December 31, 2018 -11.43M
September 30, 2018 -11.98M
June 30, 2018 -8.249M
March 31, 2018 -5.98M
December 31, 2017 -8.826M
September 30, 2017 -3.098M
June 30, 2017 -2.447M
March 31, 2017 -2.011M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

-30.49M
Minimum
Dec 2020
-7.569M
Maximum
Mar 2024
-20.74M
Average
-20.65M
Median

Cash from Operations (Quarterly) Benchmarks

Axonics Inc -9.236M
Catalent Inc 12.00M
AIM ImmunoTech Inc -9.758M
Protalix BioTherapeutics Inc 4.188M
Armata Pharmaceuticals Inc -10.58M

Cash from Operations (Quarterly) Related Metrics

Cash from Financing (Quarterly) 0.03M
Free Cash Flow -50.48M
Free Cash Flow Per Share (Quarterly) -0.169
Free Cash Flow Yield -81.33%